Genomic markers of ovarian reserve

Seminars in Reproductive Medicine

Volumn 31, Issue 6, 2013, Pages 399-415

  Wood, Michelle A ^a   Rajkovic, Aleksandar ^a,b,c  

^a Department of Obstetrics Gynecology and Reproductive Sciences   (United States)

^b Department of Pathology ^*  (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

menopause; ovarian reserve; premature ovarian failure

Indexed keywords

AROMATASE; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 15; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYTOCHROME P450; CYTOPLASMIC POLYADENYLATION ELEMENT BINDING PROTEIN; FETUIN B; FRAGILE X MENTAL RETARDATION PROTEIN; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; GROWTH DIFFERENTIATION FACTOR 9; GUANINE NUCLEOTIDE EXCHANGE FACTOR; JAGGED1; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN S6; SOMATOMEDIN B RECEPTOR;

AGING; ALLELE; ARTICLE; CHROMOSOME ABERRATION; DNA REPAIR; DOUBLE STRANDED DNA BREAK; EARLY MENOPAUSE; EMBRYO DEVELOPMENT; ESSENTIAL GENE; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC VARIABILITY; GENOMICS; GRANULOSA CELL; HEREDITY; HOMOLOGOUS RECOMBINATION; HORMONAL REGULATION; HUMAN; MENOPAUSE; NONHUMAN; ONCOGENE C KIT; OOCYTE DEVELOPMENT; OOCYTE MATURATION; OVARIAN RESERVE; OVARY DEVELOPMENT; OVARY FOLLICLE; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; PEDIGREE; PREMATURE OVARIAN FAILURE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPERMATOGENESIS; TRANSCRIPTION INITIATION; TRANSGENIC ANIMAL; ADULT; ANIMAL; GENETIC EPIGENESIS; GENETICS; METABOLISM; OVARY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIMARY OVARIAN INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

ADULT; ANIMALS; BIOLOGICAL MARKERS; EPIGENESIS, GENETIC; FEMALE; HUMANS; OOGENESIS; OVARY; PRIMARY OVARIAN INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

EID: 84885367472     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0033-1356476     Document Type: Article

References (186)

1. Mathews T. J., Hamilton B. E. Delayed childbearing: more women are having their first child later in life. NCHS Data Brief. Vol. 21. Centers for Disease Control and Prevention U.S. Department of Health and Human Services: 2009
2. Milan A. Fertility: overview, 2009 to 2011. Report on the Demographic Situation in Canada. Component of Statistics Canada Catalogue no. 91-209-X. Government of Canada; 2013
3. Broekmans F. J., Soules M. R., Fauser B. C. Ovarian aging: mechanisms and clinical consequences. Endocr Rev: 2009; 30 5 465 493
4. Rosen M. P., Johnstone E., McCulloch C. E., et al. A characterization of the relationship of ovarian reserve markers with age. Fertil Steril: 2012; 97 1 238 243
5. Jagarlamudi K., Rajkovic A. Oogenesis: transcriptional regulators and mouse models. Mol Cell Endocrinol: 2012; 356 1-2 31 39
6. Sarraj M. A., Drummond A. E. Mammalian foetal ovarian development: consequences for health and disease. Reproduction: 2012; 143 2 151 163
7. Palma G. A., Argañaraz M. E., Barrera A. D., Rodler D., Mutto A. A., Sinowatz F. Biology and biotechnology of follicle development. Scientific World Journal: 2012; 2012 938138
8. Persani L., Rossetti R., Cacciatore C. Genes involved in human premature ovarian failure. J Mol Endocrinol: 2010; 45 5 257 279
9. McGee E. A., Hsueh A. J. Initial and cyclic recruitment of ovarian follicles. Endocr Rev: 2000; 21 2 200 214 (Pubitemid 32275595)
10. Johnson J., Canning J., Kaneko T., Pru J. K., Tilly J. L. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature: 2004; 428 6979 145 150 (Pubitemid 38374304)
11. Li J., Kawamura K., Cheng Y., et al. Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci U S A: 2010; 107 22 10280 10284
12. Jin M., Yu Y., Huang H. An update on primary ovarian insufficiency. Sci China Life Sci: 2012; 55 8 677 686
13. Morris D. H., Jones M. E., Schoemaker M. J., Ashworth A., Swerdlow A. J. Familial concordance for age at natural menopause: results from the Breakthrough Generations Study. Menopause: 2011; 18 9 956 961
14. Murabito J. M., Yang Q., Fox C., Wilson P. W., Cupples L. A. Heritability of age at natural menopause in the Framingham Heart Study. J Clin Endocrinol Metab: 2005; 90 6 3427 3430 (Pubitemid 41014308)
15. van Asselt K. M., Kok H. S., Pearson P. L., et al. Heritability of menopausal age in mothers and daughters. Fertil Steril: 2004; 82 5 1348 1351 (Pubitemid 39469459)
16. Snieder H., MacGregor A. J., Spector T. D. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab: 1998; 83 6 1875 1880 (Pubitemid 28496309)
17. Simpson J. L., Rajkovic A. Ovarian differentiation and gonadal failure. Am J Med Genet: 1999; 89 4 186 200 (Pubitemid 30180704)
18. Soyal S. M., Amleh A., Dean J. FIGalpha, a germ cell-specific transcription factor required for ovarian follicle formation. Development: 2000; 127 21 4645 4654
19. Bayne R. A., Martins da Silva S. J., Anderson R. A. Increased expression of the FIGLA transcription factor is associated with primordial follicle formation in the human fetal ovary. Mol Hum Reprod: 2004; 10 6 373 381 (Pubitemid 38714369)
20. Zhao H., Chen Z. J., Qin Y., et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet: 2008; 82 6 1342 1348
21. Huntriss J., Gosden R., Hinkins M., et al. Isolation, characterization and expression of the human Factor In the Germline alpha (FIGLA) gene in ovarian follicles and oocytes. Mol Hum Reprod: 2002; 8 12 1087 1095 (Pubitemid 36032846)
22. Pangas S. A., Choi Y., Ballow D. J., et al. Oogenesis requires germ cell-specific transcriptional regulators Sohlh1 and Lhx8. Proc Natl Acad Sci U S A: 2006; 103 21 8090 8095 (Pubitemid 43801057)
23. Pangas S. A. Regulation of the ovarian reserve by members of the transforming growth factor beta family. Mol Reprod Dev: 2012; 79 10 666 679
24. Choi Y., Yuan D., Rajkovic A. Germ cell-specific transcriptional regulator sohlh2 is essential for early mouse folliculogenesis and oocyte-specific gene expression. Biol Reprod: 2008; 79 6 1176 1182
25. Choi Y., Ballow D. J., Xin Y., Rajkovic A. Lim homeobox gene, lhx8, is essential for mouse oocyte differentiation and survival. Biol Reprod: 2008; 79 3 442 449
26. Qin Y., Zhao H., Kovanci E., Simpson J. L., Chen Z. J., Rajkovic A. Analysis of LHX8 mutation in premature ovarian failure. Fertil Steril: 2008; 89 4 1012 1014 (Pubitemid 351491215)
27. Suzumori N., Yan C., Matzuk M. M., Rajkovic A. Nobox is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes. Mech Dev: 2002; 111 1-2 137 141 (Pubitemid 34136985)
28. Rajkovic A., Pangas S. A., Ballow D., Suzumori N., Matzuk M. M. NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science: 2004; 305 5687 1157 1159 (Pubitemid 39100329)
29. Lechowska A., Bilinski S., Choi Y., Shin Y., Kloc M., Rajkovic A. Premature ovarian failure in nobox-deficient mice is caused by defects in somatic cell invasion and germ cell cyst breakdown. J Assist Reprod Genet: 2011; 28 7 583 589
30. Choi Y., Qin Y., Berger M. F., Ballow D. J., Bulyk M. L., Rajkovic A. Microarray analyses of newborn mouse ovaries lacking Nobox. Biol Reprod: 2007; 77 2 312 319 (Pubitemid 47173614)
31. Choi Y., Rajkovic A. Genetics of early mammalian folliculogenesis. Cell Mol Life Sci: 2006; 63 5 579 590
32. Huntriss J., Hinkins M., Picton H. M. cDNA cloning and expression of the human NOBOX gene in oocytes and ovarian follicles. Mol Hum Reprod: 2006; 12 5 283 289 (Pubitemid 43821791)
33. Qin Y., Choi Y., Zhao H., Simpson J. L., Chen Z. J., Rajkovic A. NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet: 2007; 81 3 576 581 (Pubitemid 47330215)
34. Bouilly J., Bachelot A., Broutin I., Touraine P., Binart N. Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort. Hum Mutat: 2011; 32 10 1108 1113
35. Sehested L. T., Moller R. S., Bache I., et al. Deletion of 7q34-q36.2 in two siblings with mental retardation, language delay, primary amenorrhea, and dysmorphic features. Am J Med Genet A: 2010; 152A 12 3115 3119
36. Rossi E., Verri A. P., Patricelli M. G., et al. A 12Mb deletion at 7q33-q35 associated with autism spectrum disorders and primary amenorrhea. Eur J Med Genet: 2008; 51 6 631 638
37. Wang J., Wang B., Song J., et al. New candidate gene POU5F1 associated with premature ovarian failure in Chinese patients. Reprod Biomed Online: 2011; 22 3 312 316
38. Nilsson E. E., Kezele P., Skinner M. K. Leukemia inhibitory factor (LIF) promotes the primordial to primary follicle transition in rat ovaries. Mol Cell Endocrinol: 2002; 188 1-2 65 73 (Pubitemid 34242667)
39. Barrios F., Filipponi D., Campolo F., et al. SOHLH1 and SOHLH2 control Kit expression during postnatal male germ cell development. J Cell Sci: 2012; 125 Pt 6 1455 1464
40. Huang E. J., Manova K., Packer A. I., Sanchez S., Bachvarova R. F., Besmer P. The murine steel panda mutation affects kit ligand expression and growth of early ovarian follicles. Dev Biol: 1993; 157 1 100 109 (Pubitemid 23164959)
41. Kuroda H., Terada N., Nakayama H., Matsumoto K., Kitamura Y. Infertility due to growth arrest of ovarian follicles in Sl/Slt mice. Dev Biol: 1988; 126 1 71 79 (Pubitemid 18077586)
42. McCoshen J. A., McCallion D. J. A study of the primordial germ cells during their migratory phase in Steel mutant mice. Experientia: 1975; 31 5 589 590
43. Smith E. R., Yeasky T., Wei J. Q., et al. White spotting variant mouse as an experimental model for ovarian aging and menopausal biology. Menopause: 2012; 19 5 588 596
44. Hui E. S., Udofa E. A., Soto J., et al. Investigation of the human stem cell factor KIT ligand gene, KITLG, in women with 46,XX spontaneous premature ovarian failure. Fertil Steril: 2006; 85 5 1502 1507
45. John G. B., Gallardo T. D., Shirley L. J., Castrillon D. H. Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth. Dev Biol: 2008; 321 1 197 204
46. Reddy P., Liu L., Adhikari D., et al. Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science: 2008; 319 5863 611 613 (Pubitemid 351197061)
47. John G. B., Shidler M. J., Besmer P., Castrillon D. H. Kit signaling via PI3K promotes ovarian follicle maturation but is dispensable for primordial follicle activation. Dev Biol: 2009; 331 2 292 299
48. Edson M. A., Nagaraja A. K., Matzuk M. M. The mammalian ovary from genesis to revelation. Endocr Rev: 2009; 30 6 624 712
49. Sullivan S. D., Castrillon D. H. Insights into primary ovarian insufficiency through genetically engineered mouse models. Semin Reprod Med: 2011; 29 4 283 298
50. Reddy P., Adhikari D., Zheng W., et al. PDK1 signaling in oocytes controls reproductive aging and lifespan by manipulating the survival of primordial follicles. Hum Mol Genet: 2009; 18 15 2813 2824
51. Adhikari D., Risal S., Liu K., Shen Y. Pharmacological inhibition of mTORC1 prevents over-activation of the primordial follicle pool in response to elevated PI3K signaling. PLoS ONE: 2013; 8 1 e53810
52. Adhikari D., Gorre N., Risal S., et al. The safe use of a PTEN inhibitor for the activation of dormant mouse primordial follicles and generation of fertilizable eggs. PLoS ONE: 2012; 7 6 e39034
53. Zhao Z., Qin Y., Ma J., et al. PTEN gene analysis in premature ovarian failure patients. Acta Obstet Gynecol Scand: 2011; 90 6 678 679
54. Shimizu Y., Kimura F., Takebayashi K., Fujiwara M., Takakura K., Takahashi K. Mutational analysis of the PTEN gene in women with premature ovarian failure. Acta Obstet Gynecol Scand: 2009; 88 7 824 825
55. John G. B., Shirley L. J., Gallardo T. D., Castrillon D. H. Specificity of the requirement for Foxo3 in primordial follicle activation. Reproduction: 2007; 133 5 855 863 (Pubitemid 47162577)
56. Liu L., Rajareddy S., Reddy P., et al. Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a. Development: 2007; 134 1 199 209 (Pubitemid 46152720)
57. Rajareddy S., Reddy P., Du C., et al. p27kip1 (cyclin-dependent kinase inhibitor 1B) controls ovarian development by suppressing follicle endowment and activation and promoting follicle atresia in mice. Mol Endocrinol: 2007; 21 9 2189 2202 (Pubitemid 47347381)
58. Halperin J., Devi S. Y., Elizur S., et al. Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect. Mol Endocrinol: 2008; 22 2 513 522 (Pubitemid 351185946)
59. Wang B., Ni F., Li L., et al. Analysis of cyclin-dependent kinase inhibitor 1B mutation in Han Chinese women with premature ovarian failure. Reprod Biomed Online: 2010; 21 2 212 214
60. Ojeda D., Lakhal B., Fonseca D. J., et al. Sequence analysis of the CDKN1B gene in patients with premature ovarian failure reveals a novel mutation potentially related to the phenotype. Fertil Steril: 2011; 95 8 2658 2660, e1
61. Gallardo T. D., John G. B., Bradshaw K., et al. Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrhea. Hum Reprod: 2008; 23 1 216 221 (Pubitemid 351767308)
62. Solc P., Schultz R. M., Motlik J. Prophase I arrest and progression to metaphase I in mouse oocytes: comparison of resumption of meiosis and recovery from G2-arrest in somatic cells. Mol Hum Reprod: 2010; 16 9 654 664
63. Perry J. R., Corre T., Esko T., et al. ReproGen Consortium. A genome-wide association study of early menopause and the combined impact of identified variants. Hum Mol Genet: 2013; 22 7 1465 1472
64. Greenfeld C. R., Pepling M. E., Babus J. K., Furth P. A., Flaws J. A. BAX regulates follicular endowment in mice. Reproduction: 2007; 133 5 865 876 (Pubitemid 47162578)
65. Perez G. I., Jurisicova A., Wise L., et al. Absence of the proapoptotic Bax protein extends fertility and alleviates age-related health complications in female mice. Proc Natl Acad Sci U S A: 2007; 104 12 5229 5234 (Pubitemid 47186204)
66. Dong J., Albertini D. F., Nishimori K., Kumar T. R., Lu N., Matzuk M. M. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature: 1996; 383 6600 531 535 (Pubitemid 26346180)
67. Galloway S. M., McNatty K. P., Cambridge L. M., et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet: 2000; 25 3 279 283 (Pubitemid 30437312)
68. Yan C., Wang P., DeMayo J., et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol: 2001; 15 6 854 866 (Pubitemid 32510635)
69. Dixit H., Rao L. K., Padmalatha V., et al. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause: 2005; 12 6 749 754 (Pubitemid 41669128)
70. Zhao H., Qin Y., Kovanci E., Simpson J. L., Chen Z. J., Rajkovic A. Analyses of GDF9 mutation in 100 Chinese women with premature ovarian failure. Fertil Steril: 2007; 88 5 1474 1476 (Pubitemid 350030087)
71. Laissue P., Christin-Maitre S., Touraine P., et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol: 2006; 154 5 739 744 (Pubitemid 43810861)
72. Kovanci E., Rohozinski J., Simpson J. L., Heard M. J., Bishop C. E., Carson S. A. Growth differentiating factor-9 mutations may be associated with premature ovarian failure. Fertil Steril: 2007; 87 1 143 146 (Pubitemid 46013880)
73. Takebayashi K., Takakura K., Wang H., Kimura F., Kasahara K., Noda Y. Mutation analysis of the growth differentiation factor-9 and -9B genes in patients with premature ovarian failure and polycystic ovary syndrome. Fertil Steril: 2000; 74 5 976 979
74. Dixit H., Rao L. K., Padmalatha V. V., et al. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet: 2006; 119 4 408 415
75. Tiotiu D., Alvaro Mercadal B., Imbert R., et al. Variants of the BMP15 gene in a cohort of patients with premature ovarian failure. Hum Reprod: 2010; 25 6 1581 1587
76. Lakhal B., Laissue P., Braham R., et al. A novel BMP15 variant, potentially affecting the signal peptide, in a familial case of premature ovarian failure. Clin Endocrinol (Oxf): 2009; 71 5 752 753
77. Di Pasquale E., Rossetti R., Marozzi A., et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab: 2006; 91 5 1976 1979
78. Zhang P., Shi Y. H., Wang L. C., Chen Z. J. Sequence variants in exons of the BMP-15 gene in Chinese patients with premature ovarian failure. Acta Obstet Gynecol Scand: 2007; 86 5 585 589 (Pubitemid 46676313)
79. Chand A. L., Ponnampalam A. P., Harris S. E., Winship I. M., Shelling A. N. Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure. Fertil Steril: 2006; 86 4 1009 1012 (Pubitemid 44485024)
80. Voorhuis M., Broekmans F. J., Fauser B. C., Onland-Moret N. C., van der Schouw Y. T. Genes involved in initial follicle recruitment may be associated with age at menopause. J Clin Endocrinol Metab: 2011; 96 3 E473 E479
81. Kuo F. T., Fan K., Bentsi-Barnes I., Barlow G. M., Pisarska M. D. Mouse forkhead L2 maintains repression of FSH-dependent genes in the granulosa cell. Reproduction: 2012; 144 4 485 494
82. Laissue P., Lakhal B., Benayoun B. A., et al. Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2. J Med Genet: 2009; 46 7 455 457
83. Chatterjee S., Modi D., Maitra A., et al. Screening for FOXL2 gene mutations in women with premature ovarian failure: an Indian experience. Reprod Biomed Online: 2007; 15 5 554 560 (Pubitemid 350167078)
84. Bodega B., Porta C., Crosignani P. G., Ginelli E., Marozzi A. Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure. Mol Hum Reprod: 2004; 10 8 555 557 (Pubitemid 39136813)
85. Harris S. E., Chand A. L., Winship I. M., Gersak K., Aittomäki K., Shelling A. N. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod: 2002; 8 8 729 733
86. Braem M. G., Voorhuis M., van der Schouw Y. T., et al. Interactions between genetic variants in AMH and AMHR2 may modify age at natural menopause. PLoS ONE: 2013; 8 3 e59819
87. Kevenaar M. E., Themmen A. P., Rivadeneira F., et al. A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity. Hum Reprod: 2007; 22 9 2382 2388 (Pubitemid 47289053)
88. Dupont S., Krust A., Gansmuller A., Dierich A., Chambon P., Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development: 2000; 127 19 4277 4291
89. Toda K., Takeda K., Okada T., et al. Targeted disruption of the aromatase P450 gene (Cyp19) in mice and their ovarian and uterine responses to 17beta-oestradiol. J Endocrinol: 2001; 170 1 99 111 (Pubitemid 32677571)
90. Aittomäki K., Lucena J. L., Pakarinen P., et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell: 1995; 82 6 959 968
91. Jiang M., Aittomäki K., Nilsson C., et al. The frequency of an inactivating point mutation (566C->T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry. J Clin Endocrinol Metab: 1998; 83 12 4338 4343 (Pubitemid 29100132)
92. Doherty E., Pakarinen P., Tiitinen A., et al. A Novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J Clin Endocrinol Metab: 2002; 87 3 1151 1155 (Pubitemid 36121080)
93. Achrekar S. K., Modi D. N., Meherji P. K., Patel Z. M., Mahale S. D. Follicle stimulating hormone receptor gene variants in women with primary and secondary amenorrhea. J Assist Reprod Genet: 2010; 27 6 317 326
94. Zerbetto I., Gromoll J., Luisi S., et al. Follicle-stimulating hormone receptor and DAZL gene polymorphisms do not affect the age of menopause. Fertil Steril: 2008; 90 6 2264 2268
95. La Marca A., Sighinolfi G., Argento C., et al. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization. Fertil Steril: 2013; 99 4 970 978, e1
96. He C., Kraft P., Chasman D. I., et al. A large-scale candidate gene association study of age at menarche and age at natural menopause. Hum Genet: 2010; 128 5 515 527
97. Spencer K. L., Malinowski J., Carty C. L., et al. Genetic variation and reproductive timing: African American women from the Population Architecture using Genomics and Epidemiology (PAGE) Study. PLoS ONE: 2013; 8 2 e55258
98. Seldin M. F., Pasaniuc B., Price A. L. New approaches to disease mapping in admixed populations. Nat Rev Genet: 2011; 12 8 523 528
99. Rosenberg N. A., Huang L., Jewett E. M., Szpiech Z. A., Jankovic I., Boehnke M. Genome-wide association studies in diverse populations. Nat Rev Genet: 2010; 11 5 356 366
100. Kim S., Pyun J. A., Cha D. H., Ko J. J., Kwack K. Epistasis between FSHR and CYP19A1 polymorphisms is associated with premature ovarian failure. Fertil Steril: 2011; 95 8 2585 2588
101. Kim S., Pyun J. A., Kang H., Kim J., Cha D. H., Kwack K. Epistasis between CYP19A1 and ESR1 polymorphisms is associated with premature ovarian failure. Fertil Steril: 2011; 95 1 353 356
102. Qin Y., Sun M., You L., et al. ESR1, HK3 and BRSK1 gene variants are associated with both age at natural menopause and premature ovarian failure. Orphanet J Rare Dis: 2012; 7 5
103. Kim H., Chun S., Gu B. S., Ku S. Y., Kim S. H., Kim J. G. Relationship between inhibin-α gene polymorphisms and premature ovarian failure in Korean women. Menopause: 2011; 18 11 1232 1236
104. Yoon S. H., Choi Y. M., Hong M. A., et al. Inhibin α gene promoter polymorphisms in Korean women with idiopathic premature ovarian failure. Hum Reprod: 2012; 27 6 1870 1873
105. Harris S. E., Chand A. L., Winship I. M., et al. INHA promoter polymorphisms are associated with premature ovarian failure. Mol Hum Reprod: 2005; 11 11 779 784 (Pubitemid 43205485)
106. Corre T., Schuettler J., Bione S., et al. Italian Network for the study of Ovarian Dysfunctions. A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure. Hum Reprod: 2009; 24 8 2023 2028
107. Woad K. J., Pearson S. M., Harris S. E., Gersak K., Shelling A. N. Investigating the association between inhibin alpha gene promoter polymorphisms and premature ovarian failure. Fertil Steril: 2009; 91 1 62 66
108. Yang J. J., Cho L. Y., Lim Y. J., et al. Estrogen receptor-1 genetic polymorphisms for the risk of premature ovarian failure and early menopause. J Womens Health (Larchmt): 2010; 19 2 297 304
109. Cordts E. B., Santos A. A., Peluso C., Bianco B., Barbosa C. P., Christofolini D. M. Risk of premature ovarian failure is associated to the PvuII polymorphism at estrogen receptor gene ESR1. J Assist Reprod Genet: 2012; 29 12 1421 1425
110. M'Rabet N., Moffat R., Helbling S., Kaech A., Zhang H., de Geyter C. The CC-allele of the PvuII polymorphic variant in intron 1 of the α-estrogen receptor gene is significantly more prevalent among infertile women at risk of premature ovarian aging. Fertil Steril: 2012; 98 4 965 972, e1-e5
111. Fogli A., Gauthier-Barichard F., Schiffmann R., et al. Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure. BMC Womens Health: 2004; 4 1 8
112. Kumar K. A., Rao K. L., Vedula S. V., et al. Screening of the galactose-1-phosphate uridyltransferase gene in Indian women with ovarian failure. Reprod Biomed Online: 2005; 11 4 444 448 (Pubitemid 41762061)
113. Jasti S., Warren B. D., McGinnis L. K., Kinsey W. H., Petroff B. K., Petroff M. G. The autoimmune regulator prevents premature reproductive senescence in female mice. Biol Reprod: 2012; 86 4 110
114. Edson M. A., Nalam R. L., Clementi C., et al. Granulosa cell-expressed BMPR1A and BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development. Mol Endocrinol: 2010; 24 6 1251 1266
115. Di Giacomo M., Barchi M., Baudat F., Edelmann W., Keeney S., Jasin M. Distinct DNA-damage-dependent and -independent responses drive the loss of oocytes in recombination-defective mouse mutants. Proc Natl Acad Sci U S A: 2005; 102 3 737 742 (Pubitemid 40282735)
116. Shen C., Delahanty R. J., Gao Y. T., et al. Evaluating GWAS-identified SNPs for age at natural menopause among Chinese women. PLoS ONE: 2013; 8 3 e58766
117. Stolk L., Perry J. R., Chasman D. I., et al. Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet: 2012; 44 3 260 268
118. Pedersen T., Peters H. Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil: 1968; 17 3 555 557
119. Lu C., Lin L., Tan H., et al. Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice. Hum Mol Genet: 2012; 21 23 5039 5047
120. Rohr J., Allen E. G., Charen K., et al. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum Reprod: 2008; 23 5 1220 1225 (Pubitemid 351757318)
121. Gleicher N., Weghofer A., Barad D. H. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril: 2009; 91 5 1700 1706
122. Spath M. A., Feuth T. B., Allen E. G., et al. Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers. Hum Reprod: 2011; 26 8 2185 2191
123. Portnoï M. F., Aboura A., Tachdjian G., et al. Molecular cytogenetic studies of Xq critical regions in premature ovarian failure patients. Hum Reprod: 2006; 21 9 2329 2334 (Pubitemid 44530607)
124. Ceylaner G., Altinkaya S. O., Mollamahmutoglu L., Ceylaner S. Genetic abnormalities in Turkish women with premature ovarian failure. Int J Gynaecol Obstet: 2010; 110 2 122 124
125. Jiao X., Qin C., Li J., et al. Cytogenetic analysis of 531 Chinese women with premature ovarian failure. Hum Reprod: 2012; 27 7 2201 2207
126. Rao Kandukuri L., Padmalatha V., Kanakavalli M., et al. Unique case reports associated with ovarian failure: necessity of two intact x chromosomes. Case Rep Genet.: 2012; 2012 640563
127. Lakhal B., Braham R., Berguigua R., et al. Cytogenetic analyses of premature ovarian failure using karyotyping and interphase fluorescence in situ hybridization (FISH) in a group of 1000 patients. Clin Genet: 2010; 78 2 181 185
128. Zhang P., Shi Y., Gao X., Wang S., Wang J., Chen Z. J. Clinical analysis of Chinese infertility women with premature ovarian failure. Neuroendocrinol Lett: 2007; 28 5 580 584
129. Lo T. K., Lo I. F., Chan W. K., Tong T. M., Lam S. T. Chromosomal abnormalities and FMR1 gene premutation in Chinese women with premature menopause. Hong Kong Med J: 2005; 11 4 243 250 (Pubitemid 41153245)
130. Yatsenko S. A., Rajkovic A. Chromosomal causes of infertility: the story continues. In: Viville S., Sermon K., eds. Viville & Sermon: Textbook of Human Reproductive Genetics. UK Cambridge University Press: 2013
131. Therman E., Susman B. The similarity of phenotypic effects caused by Xp and Xq deletions in the human female: a hypothesis. Hum Genet: 1990; 85 2 175 183 (Pubitemid 20222567)
132. Rossetti F., Rizzolio F., Pramparo T., et al. A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28. Eur J Hum Genet: 2004; 12 10 829 834 (Pubitemid 39406067)
133. Eggermann T., Meschede D., Schüler H., et al. Premature ovarian failure associated with a small terminal Xq deletion: narrowing the POF1 region down to Xq27.2/Xq27.3-qter. Clin Genet: 2005; 67 5 434 437 (Pubitemid 40561495)
134. Fimiani G., Laperuta C., Falco G., et al. Heterozygosity mapping by quantitative fluorescent PCR reveals an interstitial deletion in Xq26.2-q28 associated with ovarian dysfunction. Hum Reprod: 2006; 21 2 529 535 (Pubitemid 43159933)
135. Marozzi A., Manfredini E., Tibiletti M. G., et al. Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Hum Genet: 2000; 107 4 304 311
136. Rizzolio F., Bione S., Sala C., et al. Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. Hum Reprod: 2006; 21 6 1477 1483 (Pubitemid 44445025)
137. Merhi Z. O., Roberts J. L., Awonuga A. O. A case of 46,X,der(X)t(X;X) (q22.1;p11) Xq22.1->Xqter in a 12-year-old girl with premature ovarian failure. Gynecol Obstet Invest: 2007; 63 3 137 139 (Pubitemid 46514799)
138. Rizzolio F., Sala C., Alboresi S., et al. Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: a hypothesis. Hum Genet: 2007; 121 3-4 441 450 (Pubitemid 46554680)
139. Wu M. H., Tzeng C. C., Kuo P. L. Dicentric isochromosome X with premature ovarian failure: report of two cases. J Formos Med Assoc: 1993; 92 9 848 850
140. Fitzgerald P. H., Donald R. A., McCormick P. Reduced fertility in women with X chromosome abnormality. Clin Genet: 1984; 25 4 301 309 (Pubitemid 14157791)
141. Chen C. P., Su Y. N., Lin H. H., et al. De novo duplication of Xq22.1→q24 with a disruption of the NXF gene cluster in a mentally retarded woman with short stature and premature ovarian failure. Taiwan J Obstet Gynecol: 2011; 50 3 339 344
142. Guo Q. S., Qin S. Y., Zhou S. F., et al. Unbalanced translocation in an adult patient with premature ovarian failure and mental retardation detected by spectral karyotyping and array-comparative genomic hybridization. Eur J Clin Invest: 2009; 39 8 729 737
143. Baronchelli S., Villa N., Redaelli S., et al. Investigating the role of X chromosome breakpoints in premature ovarian failure. Mol Cytogenet: 2012; 5 1 32
144. Baronchelli S., Conconi D., Panzeri E., et al. Cytogenetics of premature ovarian failure: an investigation on 269 affected women. J Biomed Biotechnol: 2011; 2011 370195
145. Han J. Y., Shin J. H., Han M. S., Je G. H., Shaffer L. G. Microarray detection of a de novo der(X)t(X;11)(q28;p13) in a girl with premature ovarian failure and features of Beckwith-Wiedemann syndrome. J Hum Genet: 2006; 51 7 641 643 (Pubitemid 44048699)
146. Dell'edera D., Tinelli A., Capozzi O., et al. Clinical correlation between premature ovarian failure and a chromosomal anomaly in a 22-year-old Caucasian woman: a case report. J Med Case Reports: 2012; 6 1 368
147. Bertini V., Ghirri P., Bicocchi M. P., Simi P., Valetto A. Molecular cytogenetic definition of a translocation t(X;15) associated with premature ovarian failure. Fertil Steril: 2010; 94 3 e5 e8
148. Giacomozzi C., Gullotta F., Federico G., Colapietro I., Nardone A. M., Cianfarani S. Premature ovarian failure, absence of pubic and axillary hair with de novo 46,X,t(X;15)(q24;q26.3). Am J Med Genet A: 2010; 152A 5 1305 1309
149. Fusco F., Paciolla M., Chen E., et al. Genetic and molecular analysis of a new unbalanced X;18 rearrangement: localization of the diminished ovarian reserve disease locus in the distal Xq POF1 region. Hum Reprod: 2011; 26 11 3186 3196
150. Misceo D., Rodningen O. K., Baroy T., et al. A translocation between Xq21.33 and 22q13.33 causes an intragenic SHANK3 deletion in a woman with Phelan-McDermid syndrome and hypergonadotropic hypogonadism. Am J Med Genet A: 2011; 155A 2 403 408
151. Cheng D. H., Tan Y. Q., Di Y. F., Li L. Y., Lu G. X. Crypt Y chromosome fragment resulting from an X;Y translocation in a patient with premature ovarian failure. Fertil Steril: 2009; 92 2 e3 e6
152. Quilter C. R., Karcanias A. C., Bagga M. R., et al. Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF). Hum Reprod: 2010; 25 8 2139 2150
153. McGuire M. M., Bowden W., Engel N. J., Ahn H. W., Kovanci E., Rajkovic A. Genomic analysis using high-resolution single-nucleotide polymorphism arrays reveals novel microdeletions associated with premature ovarian failure. Fertil Steril: 2011; 95 5 1595 1600
154. Aboura A., Dupas C., Tachdjian G., et al. Array comparative genomic hybridization profiling analysis reveals deoxyribonucleic acid copy number variations associated with premature ovarian failure. J Clin Endocrinol Metab: 2009; 94 11 4540 4546
155. Schuh-Huerta S. M., Johnson N. A., Rosen M. P., Sternfeld B., Cedars M. I., Reijo Pera R. A. Genetic markers of ovarian follicle number and menopause in women of multiple ethnicities. Hum Genet: 2012; 131 11 1709 1724
156. Murray A., Bennett C. E., Perry J. R., et al. ReproGen Consortium. Common genetic variants are significant risk factors for early menopause: results from the Breakthrough Generations Study. Hum Mol Genet: 2011; 20 1 186 192
157. He C., Murabito J. M. Genome-wide association studies of age at menarche and age at natural menopause. Mol Cell Endocrinol: 2012;; [Epub ahead of print]
158. Carty C. L., Spencer K. L., Setiawan V. W., et al. Replication of genetic loci for ages at menarche and menopause in the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) study. Hum Reprod: 2013; 28 6 1695 1706
159. Chen C. T., Fernández-Rhodes L., Brzyski R. G., et al. Replication of loci influencing ages at menarche and menopause in Hispanic women: the Women's Health Initiative SHARe Study. Hum Mol Genet: 2012; 21 6 1419 1432
160. He C., Kraft P., Chen C., et al. Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet: 2009; 41 6 724 728
161. Lutzmann M., Grey C., Traver S., et al. MCM8- and MCM9-deficient mice reveal gametogenesis defects and genome instability due to impaired homologous recombination. Mol Cell: 2012; 47 4 523 534
162. Yamaguchi M., Fujimori-Tonou N., Yoshimura Y., Kishi T., Okamoto H., Masai I. Mutation of DNA primase causes extensive apoptosis of retinal neurons through the activation of DNA damage checkpoint and tumor suppressor p53. Development: 2008; 135 7 1247 1257 (Pubitemid 351622469)
163. Lehner B., Semple J. I., Brown S. E., Counsell D., Campbell R. D., Sanderson C. M. Analysis of a high-throughput yeast two-hybrid system and its use to predict the function of intracellular proteins encoded within the human MHC class III region. Genomics: 2004; 83 1 153 167 (Pubitemid 37518270)
164. Singal D. P., Li J., Lei K. Genetics of rheumatoid arthritis (RA): two separate regions in the major histocompatibility complex contribute to susceptibility to RA. Immunol Lett: 1999; 69 3 301 306 (Pubitemid 29459132)
165. Hashimoto M., Nakamura N., Obayashi H., et al. Genetic contribution of the BAT2 gene microsatellite polymorphism to the age-at-onset of insulin-dependent diabetes mellitus. Hum Genet: 1999; 105 3 197 199 (Pubitemid 29440660)
166. Shi J., Long J., Gao Y. T., et al. Evaluation of genetic susceptibility loci for obesity in Chinese women. Am J Epidemiol: 2010; 172 3 244 254
167. Nieters A., Conde L., Slager S. L., et al. PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. Blood: 2012; 120 23 4645 4648
168. Alazzouzi H., Domingo E., González S., et al. Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis. Hum Mol Genet: 2005; 14 2 235 239
169. Cummings J. R., Cooney R. M., Clarke G., et al. The genetics of NOD-like receptors in Crohn's disease. Tissue Antigens: 2010; 76 1 48 56
170. Tadaki H., Saitsu H., Nishimura-Tadaki A., et al. De novo 19q13.42 duplications involving NLRP gene cluster in a patient with systemic-onset juvenile idiopathic arthritis. J Hum Genet: 2011; 56 5 343 347
171. Alvarado-Kristensson M., Rodríguez M. J., Silió V., Valpuesta J. M., Carrera A. C. SADB phosphorylation of gamma-tubulin regulates centrosome duplication. Nat Cell Biol: 2009; 11 9 1081 1092
172. Lu R., Niida H., Nakanishi M. Human SAD1 kinase is involved in UV-induced DNA damage checkpoint function. J Biol Chem: 2004; 279 30 31164 31170 (Pubitemid 39037779)
173. Kishi M., Pan Y. A., Crump J. G., Sanes J. R. Mammalian SAD kinases are required for neuronal polarization. Science: 2005; 307 5711 929 932 (Pubitemid 40229230)
174. Kim K. Z., Shin A., Lee Y. S., Kim S. Y., Kim Y., Lee E. S. Polymorphisms in adiposity-related genes are associated with age at menarche and menopause in breast cancer patients and healthy women. Hum Reprod: 2012; 27 7 2193 2200
175. Barak Y., Nelson M. C., Ong E. S., et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell: 1999; 4 4 585 595 (Pubitemid 29531138)
176. Cui Y., Miyoshi K., Claudio E., et al. Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J Biol Chem: 2002; 277 20 17830 17835 (Pubitemid 34967591)
177. Long J. R., Shu X. O., Cai Q., et al. Polymorphisms of the CYP1B1 gene may be associated with the onset of natural menopause in Chinese women. Maturitas: 2006; 55 3 238 246 (Pubitemid 44419451)
178. Hefler L. A., Grimm C., Heinze G., et al. Estrogen-metabolizing gene polymorphisms and age at natural menopause in Caucasian women. Hum Reprod: 2005; 20 5 1422 1427 (Pubitemid 40790274)
179. Sinasac D. S., Moriyama M., Jalil M. A., et al. Slc25a13-knockout mice harbor metabolic deficits but fail to display hallmarks of adult-onset type II citrullinemia. Mol Cell Biol: 2004; 24 2 527 536 (Pubitemid 38057906)
180. Timpl P., Spanagel R., Sillaber I., et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet: 1998; 19 2 162 166 (Pubitemid 28248798)
181. Schwed G., May N., Pechersky Y., Calvi B. R. Drosophila minichromosome maintenance 6 is required for chorion gene amplification and genomic replication. Mol Biol Cell: 2002; 13 2 607 620 (Pubitemid 34165087)
182. May N. R., Thomer M., Murnen K. F., Calvi B. R. Levels of the origin-binding protein Double parked and its inhibitor Geminin increase in response to replication stress. J Cell Sci: 2005; 118 Pt 18 4207 4217 (Pubitemid 41488958)
183. Heard E., Turner J. Function of the sex chromosomes in mammalian fertility. Cold Spring Harb Perspect Biol: 2011; 3 10 a002675
184. Bernstein B. E., Birney E., Dunham I., Green E. D., Gunter C., Snyder M.; ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature: 2012; 489 7414 57 74
185. Meng F. T., Wang Y. L., Liu J., Zhao J., Liu R. Y., Zhou J. N. ApoE genotypes are associated with age at natural menopause in Chinese females. Age (Dordr): 2012; 34 4 1023 1032
186. He L. N., Recker R. R., Deng H. W., Dvornyk V. A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females. Maturitas: 2009; 62 1 37 41 Development